TARA SADR: Open Payments
NPI 1366177081 · SHORELINE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,684 in 79 payments from 15 companies in 2025. Trend: 2023 $552 · 2024 $2,539 · 2025 $1,684
Food & beverage: $1,684
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 16 | $380 |
| ABBVIE INC. | 17 | $307 |
| Novo Nordisk Inc | 10 | $165 |
| PFIZER INC. | 8 | $165 |
| ViiV Healthcare Company | 6 | $160 |
| Lilly USA, LLC | 4 | $86 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $70 |
| Amgen Inc. | 3 | $68 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $68 |
| Astellas Pharma US Inc | 3 | $59 |
Products named: APRETUDE, UBRELVY, Yeztugo, ELIQUIS, Ozempic, NURTEC ODT, MOUNJARO, QULIPTA.
Industry payments across WA — which companies pay providers there.
